Segment Information (Tables)

9 Months Ended

Mar. 31, 2012

Segments and Geographic Information [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Consumer Healthcare		Nutritionals		Rx Pharmaceuticals		API		Other		Unallocated expenses			Total
Third Quarter 2012
Net sales	$	448,848	$	117,683	$	155,591	$	36,951	$	18,944	$	—		$	778,017
Operating income	$	74,622	$	3,674	$	69,594	$	10,874	$	1,029	$	(13,723	)	$	146,070
Amortization of intangibles	$	2,421	$	6,637	$	8,574	$	490	$	410	$	—		$	18,532
Total assets	$	1,658,231	$	952,761	$	1,066,559	$	266,786	$	95,717	$	—		$	4,040,054
Third Quarter 2011
Net sales	$	425,025	$	124,077	$	84,383	$	41,206	$	16,872	$	—		$	691,563
Operating income	$	72,204	$	17,932	$	31,141	$	11,318	$	301	$	(9,983	)	$	122,913
Amortization of intangibles	$	2,128	$	5,790	$	2,827	$	519	$	439	$	—		$	11,703
Total assets	$	1,223,242	$	981,375	$	437,745	$	266,064	$	126,268	$	—		$	3,034,694

Year-to-Date 2012
Net sales	$	1,331,806	$	365,691	$	460,414	$	127,347	$	56,224	$	—		$	2,341,482
Operating income	$	216,342	$	19,234	$	168,892	$	37,554	$	2,579	$	(36,311	)	$	408,290
Amortization of intangibles	$	6,886	$	22,739	$	23,896	$	1,507	$	1,285	$	—		$	56,313
Year-to-Date 2011
Net sales	$	1,251,125	$	380,219	$	251,250	$	118,900	$	48,906	$	—		$	2,050,400
Operating income	$	218,917	$	56,174	$	82,091	$	31,673	$	1,098	$	(23,034	)	$	366,919
Amortization of intangibles	$	6,124	$	17,383	$	8,035	$	1,527	$	1,296	$	—		$	34,365